# Beta2-adrenergic Agonism and Muscle Remodelling

> **NCT03565302** · NA · UNKNOWN · sponsor: **Morten Hostrup, PhD** · enrollment: 72 (estimated)

## Conditions studied

- Hypertrophy
- Physiologic Hypertrophy
- Physical Activity

## Interventions

- **DRUG:** Formoterol
- **DRUG:** Terbutaline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03565302
- **Lead sponsor:** Morten Hostrup, PhD
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-25
- **Primary completion:** 2021-05-30
- **Final completion:** 2021-05-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2020-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03565302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03565302, "Beta2-adrenergic Agonism and Muscle Remodelling". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03565302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*